Skip to main content
. 2017;18(8):2255–2268. doi: 10.22034/APJCP.2017.18.8.2255

Figure 5.

Figure 5

Angio Inhibitory Activity Profile of PLL Drug Shown in Part A, subpanel (A) EAC control (B) Standard drug, 5-FU (C) PLL, 20 mg/kg b.w (D) PLL, 40 mg/kg b.w. Part B of the figure shows the protein (VEGF) expression corresponding to angiogenesis and the densitometric analysis of the VEGF protein by western blot method.